On 25 January 2012, Virtify Inc will be hosting a round table discussion of industry experts on EVMPD. Andrew Marr will be in the chair and there will be representatives from Abbott Laboratories, Grünenthal, Takeda and GlaxoSmithKline to discuss their approaches to EVMPD and how they are addressing issues that are arising. Details of the round table and Registration can be access via this link.
Andrew Marr to Chair a Panel Discussion on EVMPD – 25 January 2012
January 17, 2012 By